<DOC>
	<DOCNO>NCT01524406</DOCNO>
	<brief_summary>This safety tolerability study investigate effect HPP593 healthy volunteer limb immobilization .</brief_summary>
	<brief_title>Safety Study HPP593 Subjects During After Limb Immobilization</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Hypokinesia</mesh_term>
	<criteria>Nonsmoking . Subjects must good health , determine medical history , physical examination , vital sign , electrocardiogram ( ECG ) , clinical test result . Not restrict wheelchair confine bed . Weight ≥ 50.0 kg . BMI 18 27.5 kg/m2 , inclusive , time screen . Any following abnormality Screening Visit Baseline : Fasting glucose &gt; 110 mg/dL ( Screening visit ) . Serum creatinine &gt; 1.5 mg/dL . If serum creatinine &gt; 1.5 mg/dL creatinine clearance &gt; 60 mL/min , subject need exclude Troponin I level upper limit normal ( ULN ) Liver function test ( LFTs ) &gt; 1.5x ULN Evidence significant organ system dysfunction ( e.g . diabetes , cardiovascular disease , cirrhosis , hypogonadism , hypo hyperthyroidism ; hypertension ) Any fluctuation weight ( ± 2 % body weight ) subject self report 3 month prior Screening Visit . Has receive HPP593 previous clinical trial . Smoking within 6 month prior Day 1 . Michigan Alcohol Screening Test score great 2 .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Muscle Atrophy</keyword>
</DOC>